Citadel Advisors
ASTH icon

Citadel Advisors’s Astrana Health ASTH Stock Holding History

Citadel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
25,069
+50
+0.2% +$1.8K ﹤0.01% 7839
2026
Q1 		$613K Sell
25,019
-6,485
-21% -$154K ﹤0.01% 8791
2025
Q4 		$782K Sell
31,504
-21,014
-40% -$558K ﹤0.01% 7964
2025
Q3 		$1.49M Sell
52,518
-131,372
-71% -$3.56M ﹤0.01% 6693
2025
Q2 		$4.58M Sell
183,890
-96,409
-34% -$2.72M ﹤0.01% 4270
2025
Q1 		$8.69M Buy
+280,299
New +$9.34M ﹤0.01% 3042
2024
Q3 		– Sell
-22,181
Closed -$1.09M – 15415
2024
Q2 		$900K Sell
22,181
-22,437
-50% -$890K ﹤0.01% 6802
2024
Q1 		$1.87M Sell
44,618
-57,425
-56% -$2.24M ﹤0.01% 5656
2023
Q4 		$3.91M Sell
102,043
-72,763
-42% -$2.42M ﹤0.01% 4162
2023
Q3 		$5.39M Buy
174,806
+34,966
+25% +$1.21M ﹤0.01% 3536
2023
Q2 		$4.42M Sell
139,840
-2,668
-2% -$91.5K ﹤0.01% 3837
2023
Q1 		$5.2M Sell
142,508
-63,598
-31% -$2.23M ﹤0.01% 3742
2022
Q4 		$6.1M Sell
206,106
-57,059
-22% -$1.83M ﹤0.01% 3542
2022
Q3 		$10.3M Buy
+263,165
New +$12M ﹤0.01% 2718
2022
Q2 		– Sell
-14,360
Closed -$546K – 14287
2022
Q1 		$696K Sell
14,360
-49,388
-77% -$2.55M ﹤0.01% 8585
2021
Q4 		$4.68M Buy
63,748
+59,818
+1,522% +$4.91M ﹤0.01% 4414
2021
Q3 		$358K Buy
+3,930
New +$334K ﹤0.01% 10672
2021
Q2 		– Sell
-68,558
Closed -$1.86M – 14563
2021
Q1 		$1.86M Buy
+68,558
New +$1.65M ﹤0.01% 6563
2020
Q4 		– Sell
-25,892
Closed -$465K – 11626
2020
Q3 		$465K Buy
25,892
+10,106
+64% +$174K ﹤0.01% 7428
2020
Q2 		$261K Buy
15,786
+3,610
+30% +$56.8K ﹤0.01% 8136
2020
Q1 		$157K Buy
+12,176
New +$199K ﹤0.01% 8254
2019
Q4 		– Sell
-16,970
Closed -$299K – 9873
2019
Q3 		$299K Buy
+16,970
New +$290K ﹤0.01% 7557
2018
Q4 		– Sell
-24,175
Closed -$534K – 9862
2018
Q3 		$534K Buy
+24,175
New +$509K ﹤0.01% 6589

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors's ASTH Position: Q2 2026 in Review

Citadel Advisors increased its Astrana Health (ASTH) stake by 0.2% in Q2 2026, buying an estimated $1.8K and bringing the position to 25,069 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #7839.

Citadel Advisors first reported a position in ASTH in Q3 2018 and has held it in 23 quarters since. The position peaked at $10.3M in Q3 2022. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Citadel Advisors held 25,069 shares of Astrana Health worth $1.16M as of Q2 2026.
  • Citadel Advisors bought 50 Astrana Health shares in Q2 2026, an estimated $1.8K.
  • Astrana Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7839 holding.
  • Citadel Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 23 quarters since.
  • Citadel Advisors's Astrana Health position peaked at $10.3M in Q3 2022.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.